Heart failure (HF) is the leading cause of death worldwide. Efforts to decrease HF mortality rates include a multidisciplinary approach management. Although evidence suggests that this has been an optimal strategy for treating HF, the model remains not widely implanted. The current article explores the rationale behind the formation of a Heart Team in a developing country and its development despite the lack of an allocated budget.

Keywords:
Heart Team development, Shared decision making, Heart failure, Structural heart disease
1.
Rich M: Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 1997;45:968-974.
2.
Chávez-Domínguez R, Ramírez-Hernández JA, Casanova-Garcés J: La cardiopatía coronaria en México y su importancia clínica, epidemiológica y preventive. Arch Cardiol Mex 2003;73:105-114.
3.
Ramani GV, Uber PA, Pharm D, Mandeep RM: Cost-effectiveness analysis in clinical practice. Mayo Clin Proc 2010;85:180-195.
4.
The Organisation for Economic Co-Operation and Development (OECD): Cardiovascular Disease and Diabetes: Policies for Better Health and Quality of Care. June 2015. https://data.oecd.org/mexico.htm (accessed March 5, 2016).
5.
Head SJ, Kaul S, Mack MJ, Seruys PW, Taggart DP, Holmes DR Jr, Kappetein AP: The rationale for Heart Team decision-making for patients with stable complex coronary artery disease. Eur Heart J 2013;34:2510-2518.
6.
Jaarsma J: Health care professionals in a heart failure team. Eur J Heart Fail 2005;7:343-349.
7.
Doughty R, Wright S, Pearl A, Walsh H, Muncaster G, Whalley G, et al: Randomized, controlled trial of integrated heart failure management: the Auckland Heart Failure Management Study. Eur Heart J 2002;23:139-146.
8.
Grady KL, Kathleen D, Kennedy G, Moser DK, Piano M, Warner-Stevenson L, Young JB: Team management of patients with heart failure. Circulation 2000;102:2443-2456.
9.
Stacey D, Bennett C, Barry M, Col N, Eden K, Holmes-Rovner M: Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2011;10:CD001431.
10.
Coylewright M, Mack MJ, Holmes D, O'Gara PT: A call for an evidence-based approach to the Heart Team for patients with severe aortic stenosis. J Am Coll Cardiol 2015;65:1-9.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.